A conventional metabolic pathway leads to a specific product. In stark contrast, there are diversity-generating metabolic pathways that naturally produce different chemicals, sometimes of great diversity. We demonstrate that for one such pathway, tru, each ensuing metabolic step is slower, in parallel with the increasing potential chemical divergence generated as the pathway proceeds. Intermediates are long lived and accumulate progressively, in contrast with conventional metabolic pathways, in which the first step is rate-limiting and metabolic intermediates are shortlived. Understanding these fundamental differences enables several different practical applications, such as combinatorial biosynthesis, some of which we demonstrate here. We propose that these principles may provide a unifying framework underlying diversity-generating metabolism in many different biosynthetic pathways.natural products | secondary metabolism | biosynthesis | RiPP | cyanobactin T here are two fundamentally different types of metabolic pathways in living systems. The first are aimed to generate one or a few discrete chemicals; these comprise the majority of pathways. The second have evolved to produce large numbers of different metabolites (1, 2). Although perhaps fewer in number, this second class, which we will call "diversity generating" (DG), may be responsible for the majority of small molecules in living systems. A key difference is that the compounds produced in the latter generally have a more limited phylogenetic distribution.The metabolic pathways first elucidated were for the synthesis of essential metabolites found in all cells, such as amino acids, purines, or pyrimidines. These conventional metabolic pathways typically comprise multiple metabolic steps, with the intermediates generated in each step converted only to the final product of the pathway. DG pathways, however, do not yield a single final product. Each enzyme in a DG pathway has relaxed substrate specificity and is able to handle a variety of compounds, carrying out the same chemical transformation on different substrates.Previously, an evolutionary framework was developed to explain why some biosynthetic pathways produce many compounds (3-5). In this study we provide the first integrated overview, to our knowledge, of the multiple metabolic steps that comprise a DG biosynthetic pathway. We have uncovered striking differences in how this pathway differs from the canonical features of conventional pathways. Our results provide an initial framework for understanding how DG pathways are designed and how key features of such pathways diverge from the textbook model.We specifically examine the tru and related pat cyanobactin pathways (1, 6). These ribosomally synthesized and posttranslationally modified (RiPP) secondary metabolite pathways were identified in cyanobacterial symbionts of coral reef animals. Their expression required transfer to a model host, Escherichia coli (Fig.